Novo Nordisk’s Post

Not long now until ISPOR Europe in Copenhagen. Are you attending? If you are, do go along to our stand at C3-048 and meet with Luciana Strait and the Initiate team to find out how we can support you in your market access and health economic challenges. #ispor #isporeurope #copenhagen #marketaccess #healtheconomics #team #solutions

Sweden is a Rich Source of Real-World Evidence (RWE) and Health Data – Together with Finland, it Offers a Population of 15 Million 🌎 Real-world data (RWD) created in Finnish healthcare is comprehensive and high-quality. #Sweden, another Scandinavian country, also offers high-quality healthcare data for real-world evidence generation. -By combining the data from these two countries, we reach a population of over 15 million unique individuals, states Dr. Johanna Simin, PhD MSc, Lead RWE Epidemiologist at Medaffcon, during the EMMA event organised by #Medaffcon.  In Sweden, a vast amount of healthcare data is available at the national and regional levels, covering a long period of time. Different data sources can be linked using the Swedish personal identification number.  The information needed for real-world evidence (#RWE) research is available in Sweden from several national and regional databases, researcher-led databases, about 450 registered biobanks, and over 100 disease-specific quality registries. 🌐 Link to the whole article (ENG): https://lnkd.in/dFSPEDQf 🌐 Link to the whole article (FIN): https://lnkd.in/dmW9aJV4 #realworldevidence #pharma #database

The Multi stakeholder Hearing for 2024 UNGA HLM on AMR, which will take place in New York, USA on 15th May 2024 is now OPEN. 3 Proposed discussion Panels 💸 Panel 1: Adequate, predictable, and sustainable financing of and investments in the AMR response to support country-level implementation. •Optimizing domestic resources for sustainable impact across sectors: •Transforming international financing options for AMR 🔬 Panel 2: Addressing antimicrobial access, research and development (R&D), and innovation. •Enabling access and appropriate use of antimicrobials and accelerating R&D to address AM •Cross-sectoral system transformation for prevention, diagnosis, and treatment of AM 💡 Panel 3: Effective governance, leadership, and coordination of the AMR response at the national, regional and global levels •Strengthening national, regional and global leadership and coordination •Revitalizing the Global Action Plan on AMR The registration is via the United Nations Meetings/Events registration portal (Indico: https://lnkd.in/dwgdSxX2).   Please note the deadline for registration which is the 24th April 2024. 👉 Dr. Kefas Samson #Quadripartite #UNGA24

Hello #connections, Got the annual membership of ISCR on 18/12/2023, updated lately. Recently had a wonderful experience with a ISCR webinar on "Crafting a protocol for RWE (Real World Evidence) studies", got the opportunity to learn about clinical research more. Currently also reading PICR (Perspectives in Clinical Research) , the official publication of ISCR, volume 15/ issue 1/ January-March 2024. I hope the membership will help to learn new informations more about clinical research and will have new experiences. #iscr #clinicalresearch

🇸🇪 🇩🇰Yesterday Sigrid Therapeutics AB was privileged to participate in a distinguished gathering at the Swedish Embassy in Copenhagen, Denmark, under the gracious hosting of Ambassador Charlotte Wrangberg. It was a distinct honor to engage with Swedish Health Minister Acko Ankarberg Johansson and an exceptional delegation representing both Swedish and Danish interests, comprising: Emelie Antoni, Astra Zeneca Cajsa Lindberg, Business Sweden Hanna Leffler, Business Sweden Anette Steenberg, Medicon Valley Alliance Anker Nystad Wittendorff, Arjo Damir Konakovic, Sigrid Therapeutics Together, we delved into discussions on optimizing collaborative efforts in the Nordic healthcare sector. Exploring pathways for enhanced cooperation between countries, private sector, public sector, and government is key to unlocking the full potential of healthcare and life sciences in our region. Sigrid underscored the urgency of shifting from a reactive to a more preventive healthcare approach. Additionally, we emphasized how innovative Nordic Health Tech and Life Science companies can thrive and play a vital role in the healthcare ecosystem, particularly in addressing chronic lifestyle diseases. #NordicHealthcare #CollaborativeInnovation #HealthcareExcellence #PublicPrivatePartnerships #SigridTherapeutics #BusinessSweden #AstraZeneca #MediconValleyAlliance #Arjo 🌍🔬💡

📢Following the launch of the pan-European Health Outcomes Observatory, we are thrilled to introduce the newly appointed members of the Board. Congratulations to: 🔹 Dr Jørgen Schøler Kristensen (Chairman of the Danish Medicines Council), who will serve as Chair 🔹 Dr Linetta Koppert (Dutch H2O), who will serve as Vice-Chair 🔹Andreas Christodoulou (European Patients' Forum Board Member), who will join the Board as Treasurer; and 🔹Board Members Dr Matthias Rose (German H2O), Dr Pilar Rodriguez Ledo (Spanish H2O), and Héctor Röthlisberger. This marks a significant milestone for the H2O initiative, now including the pan-European Observatory and national observatories in Austria, Germany, the Netherlands, and Spain. We are eager to expand further, promoting patient empowerment and advancing health research across #Europe and beyond. Read our press release on the launch of the pan-European Health Outcomes Observatory 👉 https://lnkd.in/eMnc8WTF Innovative Health Initiative (IHI), EFPIA - European Federation of Pharmaceutical Industries and Associations, European Patients' Forum, Trial Nation, JDRF International, Teamit #InnovativeHealthInitiative #HealthcareInnovation #DataAnalytics #HealthOutcomes #HealthResearch #DataDrivenHealthcare #InnovateHealth #HealthcareRevolution

Innovations in healthcare often require fine tuning of the Healthcare System (HCS). This also applies to RadioLigand Therapies (RLT), a novel way of treating cancer patients, for which it's imperative that Healthcare System Stakeholders work together. 🎥 This Webinar will share what we've learned so far and what needs to happen to prepare HCS and to ensure patients have timely and equitable access to Radioligand Therapies #RLT Register below to hear from an exquisite panel of experts! 🔽

Let’s talk about pharmaceutical #innovation and the revolution our medicines bring to Society and Economy!

It is a dream come true; I know it sounds like a shallow soundbite, but it is anything but… 6 years ago I had such a dream. The dream of patients being in control of their data, being able to measure how they are doing in a way that is understood by healthcare providers and being able to be to part of any decision that affects their lives. Not out of pity or compassion; but because they have the data and the evidence to prove their point. 6 years ago the #EHDS was not even at the horizon; however there is a tremendous opportunity for synergies now. The Pan-European Observatory can serve as a forum to achieve consensus on what can be measured digitally in routine care in order to improve care and fuel the EHDS with standardized outcome data. At the same time, the data access framework developed through the H2O project offers a blueprint on how to manage data by relying on the Patient Agreement. H2O through the leadership of the Pan-European Health Outcomes Observatory can pave the way on how to build the EHDS on the foundation of 'Data Trusts' and multi-stakeholder consensus on what to measure and how.

Webinar alert ‼️ Join me on July 11th at 4PM CET for an exciting webinar on the use of polynucleotides in treating facial erythema.   Polynucleotide injections have been widely used in Asian countries, primarily South Korea, for the treatment of facial erythema.   What you will learn: - An overview of the available clinical data - Insights from data collected in countries where Pluryal PN products have been used for treating facial erythema, particularly rosacea. - The protocols used for these treatments. - The results and patient feedback. Secure your spot here as places are limited: https://bit.ly/4cetxPB #pluryal